We are live on ! Find out more
NVCR icon

NovoCure
NVCR

238 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $5.74M

64% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 61

10% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 40

3.34% more ownership

Funds ownership: 82.04% → 85.38% (+3.3%)

4% more capital invested

Capital invested by funds: $1.19B → $1.24B (+$50.9M)

2% less funds holding

Funds holding: 244 → 238 (-6)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
238
Holders Change
-6
Holders Change %
-2.46%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
44
Increased
100
Reduced
61
Closed
40
Calls
$16.7M
Puts
$5.74M
Net Calls
+$11M
Net Calls Change
-$5M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$53.3M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$14.4M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.1M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.38M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$25.8M
2
SCM
Soleus Capital Management
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$13.4M
4
UBS AM
UBS AM
Illinois
-$12.4M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AUB
226
Atlantic Union Bankshares
Virginia
$324 +$321 +25 New
AIM
227
Anchor Investment Management
South Carolina
$323 – – –
GWP
228
Gen-Wealth Partners
Michigan
$246 – – –
TCM
229
TD Capital Management
Tennessee
$233 – – –
RS
230
Rakuten Securities
Japan
$220 – – –
CW
231
Curio Wealth
Maryland
$202 +$193 +15 New
CA
232
Clearstead Advisors
Ohio
$169 -$3.52K -274 -95%
EW
233
Elyxium Wealth
California
$129 +$128 +10 New
SS
234
Sunbelt Securities
Texas
$52 – – –
GSWM
235
Golden State Wealth Management
California
$39 – – –
TPBG
236
Turning Point Benefit Group
Maryland
$38 – – –
DF
237
Dunhill Financial
United Kingdom
$28 +$26 +2 New
SA
238
Strategic Advocates
Utah
$26 -$77 -6 -75%
Capital World Investors
239
Capital World Investors
California
– -$25.8M -2,000,000 Closed
Marshall Wace
240
Marshall Wace
United Kingdom
– -$13.4M -1,034,978 Closed
FCM
241
Frontier Capital Management
Massachusetts
– -$6.22M -481,349 Closed
SCM
242
Sio Capital Management
New York
– -$5.35M -413,829 Closed
NA
243
Nordwand Advisors
Pennsylvania
– -$3.32M -256,628 Closed
DFCM
244
Dark Forest Capital Management
Puerto Rico
– -$2.3M -177,830 Closed
HSA
245
Hussman Strategic Advisors
Maryland
– -$1.09M -84,000 Closed
ECM
246
ExodusPoint Capital Management
New York
– -$1.08M -83,486 Closed
TI
247
Trexquant Investment
Connecticut
– -$893K -69,148 Closed
First Trust Advisors
248
First Trust Advisors
Illinois
– -$885K -68,470 Closed
TD Asset Management
249
TD Asset Management
Ontario, Canada
– -$317K -24,532 Closed
GWMR
250
GC Wealth Management RIA
Massachusetts
– -$297K -23,016 Closed
8 9
10
11 12

NVCR Hedge Fund Activity: Q4 2025 in Review

238 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2025, worth a combined $1.24B — up 4.3% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVCR positions and 40 closed out — a net gain of 4 holders — while 100 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $53.3M. The largest seller was Capital World Investors, exiting entirely with an estimated $25.8M sold.

  • 238 institutional investors held NovoCure (NVCR) as of Q4 2025, down from 244 in Q3 2025.
  • Funds reported $1.24B of NovoCure stock for Q4 2025, up 4.3% quarter-over-quarter.
  • 44 funds opened new NovoCure positions in Q4 2025 and 40 closed out, a net change of +4 holders.
  • The largest NovoCure buyer in Q4 2025 was Morgan Stanley, an estimated $53.3M added.
  • The largest NovoCure seller in Q4 2025 was Capital World Investors, an estimated $25.8M sold.

Based on aggregated 13F filings for Q4 2025.